Serum leptin levels in males with delayed puberty during short-term pulsatile GnRH administration
Leptin may be a possible trigger for puberty. In normal males, it has been shown that leptin increases from the pre-pubertal to the early pubertal stage, and then declines in the late pubertal stage. We examined leptin levels in six male adolescents (mean age 16.3±0.6 yr; range 14.2-17.6 yr) with delayed puberty (constitutional delay of puberty no.=2; idiopathic hypogonadotropic hypogonadism no.=4) during 120 days of subcutaneous pulsatile GnRH administration. A group of subjects in pre-puberty (no.=11), early-puberty (n=10) and mid-puberty (no.=7) were evaluated as controls. Morning blood samples were taken for determination of leptin, testosterone, LH and FSH levels. In delayed puberty subjects blood samples were taken every 30 days after the start of GnRH administration. At each examination BMI and testicular volume were evaluated. A follow-up examination was performed in the 6 patients 1.3-7.5 yr after the end of the 120 days of GnRH therapy. At baseline evaluation in delayed puberty mean leptin levels were 11.3±2.0 ώg/l (median 11.3 ώg/l; range 4.7-17.3 ώg/l) and were higher than those found in pre-puberty (p=0.04) and mid-puberty (p=0.001). During GnRH administration there was no change in BMI and leptin levels but there was an increase in gonadotrophin levels, testosterone and testicular volume. One undred and twenty days after, mean serum leptin were 10.1±2.1 ώg/l (median 9.1 ώg/l; range 3.4-16.8 ώg/l). At the end of the study, leptin levels were higher in delayed puberty than in mid-puberty (p=0.002). At the follow-up examination leptin levels were 4.3±1.3 ώg/l (median 3.4 ώg/l; range 1.4-9.1 ώg/l) (p=0.03 vs end of 120 days GnRH therapy) while testosterone and BMI were not changed. In conclusion 120-day pulsatile GnRH administration induced in males with delayed puberty physiological-like pubertal changes but not the decline in leptin levels reported during the progression of puberty. Therefore, in males with delayed puberty an impairment in the phenomenon of leptin decline associated with progression of puberty could be suggested. However after retrospective diagnosis of pubertal delay and long-term therapy in subjects with idiopathic hypogonadotropic hypogonadism leptin levels declined. These data seem to indicate that time more than increase in testosterone levels and testicular volume is the determinant of leptin decline at puberty.
Key-wordsDelayed puberty males leptin testosterone pulsatile GnRH
Unable to display preview. Download preview PDF.
- 12.Blum W.F., Englaro P., Hanitsch S., Juul A, Hertel N.T., Muller J., Skakkebek N.E., Heiman M.L., Birkett M., Attanasio A.M., Kiess W., Rascher. W. Plasma leptin levels in healthy children and adolescent: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J. Clin. Endocrinol. Metab. 82: 2904, 1997.PubMedGoogle Scholar
- 16.Wagner T.O.F., Brabant G., Warsch F., Hesch R.D. Pulsatile gonadotropin-releasing hormone treatment in idiopathic delayed puberty. J. Clin. Endocrinol. Metab. 42: 942, 1986.Google Scholar
- 17.Tanner J.M. Growth at adolescence. Blackwell Scientific Publications, Oxford, 1962.Google Scholar
- 18.Behre H.M., Yeung C.H., Nieschlag E. Diagnosis of male Infertility and Hypogonadism. In: Nieschlag E., Behre H.M. (Eds.), Andrology Male Reproductive Health and Dysfunction. Springer, Berlin, 1997, p. 87.Google Scholar
- 19.Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P., Friedman J. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med. 1: 1155, 1995.PubMedCrossRefGoogle Scholar
- 20.Pombo M., Herrera-Justiniano E., Considine R.V., Hermida R.C., Galvez M.J., Martin T., Barreiro J., Casanueva F.F., Dieguez C. Nocturnal rise of leptin in normal prepubertal and pubertal children and in patients with perinatal stalk-transection syndrome. J. Clin. Endocrinol. Metab. 82: 2751, 1997.PubMedCrossRefGoogle Scholar
- 27.Giustina A., Scalvini T., Tassi C., Desenzani P., Poiesi C., Wehrenberg W.B, Rogol A.D., Veldhuis J.D. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hy-pogonadism pharmacologically exposed to progressive increments in serum testosterone. J. Clin. Endocrinol. Metab. 82: 1210, 1997.PubMedGoogle Scholar
- 29.Giusti M., Torre R., Cavagnaro P., Attanasio R., Traverso L., Giordano G. The effect of long-term pulsatile GnRH administration on the 24-hour integrated concentration of GH in hypogonadotropic hypogonadic patients. Acta Endocrinol. (Copenh.) 120: 724, 1989.Google Scholar